Video
Capacity and Global Network Enables Flexible Manufacturing
Summary: Learn about Catalent's manufacturing capacity and robust global network. Accredited by 30+ global agencies, it supplies oral, sterile and inhaled products. Catalent has expertise in...
View Now
Video
Unlock Your Molecules Potential with Catalent
Summary: Your molecule has so much potential, we share the passion to unlock it through extensive expertise and superior formulation technologies. Learn how we have optimized thousands...
View Now
Video
Bring Pharma, Biopharma and Consumer Health Products to Market with Catalent
Summary: A short video on how Catalent can help you develop, deliver, supply better treatments. Whether it is Pharmaceuticals, Biopharmaceuticals, Over-the-Counter, Nutritionals or Beauty Care and Cosmetics, we can...
View Now
Video
Zydis® ODT - Real World Solutions for Patients
Summary: Zydis® ODT is an orally dissolving tablet formulated as for fast dissolve that requires little to no water when taking the medication. It provides an ideal dosing solution when dealing...
View Now
Video
Meet Aileen B. - GOLD Graduate
Summary: The Catalent GOLD (Global Organization Leadership Development) Program is a two-year rotational development opportunity...
View Now
Video
Career Development at Catalent
Summary: Catalent offers employees numerous opportunities for development and career progression. Hear more about what our team has to say about how Catalent supports their...
View Now
Video
Product Development Careers at Catalent
Summary: Members of our product development gain unparalleled experience working on several products using multiple technologies. Hear what it's like to work...
View Now
Webinars
Flexible Manufacturing Strategies: What’s Best For Your Product?
Summary: Watch this webinar to get insight from manufacturing experts on the benefits of end-to-end solutions and how flexible manufacturing strategies can accommodate the changing landscape of the pharmaceutical industry.
View Now
Article
Overcoming Manufacturing Challenges For Accelerated Drug Development
Summary: It has been reported that surveys of migraine patients have revealed a preference for oral medications with a rapid onset of action that leads to a resolution of their symptoms. Due to the random nature of migraine attacks..
View Now
Webinars
Overcoming Challenges for Accelerated Development
The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed.
View Now